All Stories

  1. Factors affecting survival in operated gastric cancer
  2. The prognostic effect of pretreatment 18F-FDG PET/CT metabolic parameters in locally advanced Esophageal Squamous Cell Carcinoma treated with definitive chemoradiotherapy
  3. Factors Affecting Survival in Operated Esophageal Squamous Cell Carcinoma
  4. The Predictive Value of Baseline Volumetric PET/CT Parameters on Treatment Response and Prognosis in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy
  5. Trastuzumab ± Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group
  6. The Effect of Body Mass Index on Treatment Outcomes in Patients with Metastatic Non-Small Cell Lung Cancer Treated with Platinum-Based Therapy
  7. The impact of tumor regression grade on long-term survival in locally advanced rectal cancer treated with preoperative chemoradiotherapy
  8. Factors affecting survival in operated pancreatic cancer; Does tumor localization have a significant effect on treatment outcomes?
  9. The effect of different treatment modalities on survival in elderly patients with locally advanced non-small cell lung cancer
  10. Factors affecting survival and treatment efficacy in breast cancer patients with bone marrow metastasis
  11. Clinical outcomes of patients with pure small cell carcinoma of the urinary bladder
  12. Efficacy and tolerability of adjuvant therapy in ≥70-year-old patients with T3N0M0 colorectal cancer: An observational study
  13. The evaluation of efficacy and tolerability of gemcitabine vs. capecitabine therapy in the second-line setting for metastatic pancreatic cancer patients with poor performance status
  14. The Relation between Hemogram Parameters and Survival in Extensive-Stage Small Cell Lung Cancer
  15. Prognostic impact of blood transfusion in patients with metastatic non-small cell lung cancer receiving chemotherapy
  16. Plasma thiols in prostate cancer
  17. Treatment Outcomes of Metastatic Colorectal Cancer Patients Treated with Regorafenib as Third-Line Setting-A Multicenter Study
  18. Lung cancer
  19. Factors Affecting Survival in Esophageal Squamous Cell Carcinoma: Single Center Experience
  20. Treatment Outcomes of HER-2 Positive Metastatic Breast Cancer Patients Treated with Pertuzumab in the First Line Setting- Real Life Experience
  21. The Protective Effects of Pentoxifylline on Contrast Induced Nephropathy in Rats
  22. Behçet′s disease and breast cancer: A case series study
  23. Durable complete response with a short course of streptozotocin plus doxorubicin combination in malignant metastatic insulinoma
  24. Non-Urothelial Bladder Cancer: Comparison of Clinicopathological and Prognostic Characteristics in Pure Adenocarcinoma and Non-Bilharzial Squamous Cell Carcinoma of the Bladder
  25. Çoklu Primer Tümörler-Tek Merkez Deneyimi
  26. Queries for the article entitled “Predictors for extensive nodal involvement in breast cancer patients with axillary lymph node metastases”
  27. The association between body mass index and immunohistochemical subtypes in breast cancer
  28. Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients
  29. Three-Year Disease-Free Survival After D2 Dissection and Liver Metastasectomy in a Gastric Cancer Case with Poor Prognostic Factors: A Case Report
  30. Renal cell carcinoma presenting with heart metastasis without inferior vena caval and right atrial involvement
  31. The significance of serum leptin level in patients with early stage nonsmall cell lung cancer
  32. Synchronous renal cell carcinoma and primary ocular malignant melanoma: case report
  33. Modified docetaxel, cisplatin and fluorouracil therapy as the first-line treatment for patients with recurrent/metastatic squamous cell carcinoma of the head and neck cancer: a retrospective study
  34. More data along with further definitions are required
  35. The evaluation of sleep quality and response to anti-tumor necrosis factor α therapy in rheumatoid arthritis patients
  36. Serum vitamin D levels and response to molecular subtypes in breast cancer
  37. Management of hair loss associated with endocrine therapy in patients with breast cancer: an overview
  38. Small cell carcinoma of the urinary bladder: changing trends in the current literature
  39. Panitumumab as a possible cause of hematospermia: what is the mechanism?
  40. Colon Carcinoma Metastasizing to Skin and Breast - Rare Metastasis Sites: A Case Report
  41. The highest (3600 IU) reported overdose of insulin glargine ever and management
  42. Krukenberg tumor
  43. A rare coexistence - Chronic lymphocytic leukemia and Kaposi sarcoma: Case report and review of the literature